Key Highlights
- Cash was A$3.44 million at 30 September 2026, down A$90,000 over the quarter.
- Net operating cash outflow was A$21,000, against A$952,000 in the same quarter last year.
- Sales volumes rose to 275 tonnes, while production of 457 tonnes was lower after a pause in manufacturing.
- A Federal Court class action brought by the Banton Group on behalf of some shareholders remains ongoing and is largely at discovery stage.
Phoslock Environmental Technologies Limited (ASX:PET) released its September 2026 quarterly activities report and Appendix 4C on 22 October 2026. The Sydney-headquartered water treatment company makes lanthanum modified bentonite products that bind phosphorus in lakes, rivers and reservoirs. The report covers its cash position, sales and production, new product trials and its legacy legal matters.
Cash Flow and Balance Sheet
Net operating cash outflow was A$21,000 for the quarter, a large improvement on the A$952,000 outflow in the corresponding quarter last year. Sales receipts were A$1.13 million, and net operating outlays were A$1.15 million, including legal fees of A$36,000 offset by insurance reimbursements and a A$116,000 refund of excess US Import duties.
Cash was A$3.44 million at quarter end. Net Cash Flow after investing, forex and operating items was negative A$48,000 for the quarter, and the company reports no financing facilities.
Sales and Production
Sales volumes were 275 tonnes, against 251 tonnes a year earlier and 189 tonnes in the prior quarter. Brazil accounted for 61% of sales, Australia 24%, China 12% and Europe 4%.
Production was 457 tonnes, bringing year-to-date output to 1,524 tonnes. The company paused Manufacturing at the end of August after inventory at its Changxing plant reached storage capacity, and the deferral of several European projects to the first quarter of 2027 also contributed. Inventory was 1,848 tonnes, including 983 tonnes held in China.
Product Trials
Laboratory work extended the range of new formulations to products containing 15% and 20% lanthanum, and the company has filed a Patent application. A first bulk trial of Phoslock 10 with 10% lanthanum began in a small pond at Jintan, Changzhou, with 700 kg dosed. Sampling will continue over the coming months, and further bulk trials are being sought in the United States, Europe and Australia.
Legal Matters and Risks
The company is managing a class action commenced in the Federal Court by the Banton Group on behalf of certain shareholders. The proceedings remain ongoing and largely at the discovery stage, and formal court proceedings may not take place until 2027. The company says the outcome cannot be predicted.
Other risks identified are the sensitivity of quarterly cash flows to timing of sales receipts, the inventory held at the Changxing plant and the status of European project deferrals. Future reports will show whether production resumes and whether the trial results support new product sales.
Final Word
Phoslock's quarter combined a sharp drop in operating outflow with a production pause, a growing inventory and an unresolved class action. Future reports are expected to show whether production restarts, the results of the Jintan trial and the progress of the Federal Court proceedings.




_11_17_2026_11_03_15_426436.jpg)

Please wait processing your request...